AST-120 (Kremezin®) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects
K Konishi, S Nakano, S Tsuda, A Nakagawa… - diabetes research and …, 2008 - Elsevier
There is little clinical evidence when AST-120 should be prescribed for subjects with early
stage overt diabetic nephropathy. We therefore designed a prospective, randomized …
stage overt diabetic nephropathy. We therefore designed a prospective, randomized …
Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects
S Nakano, T Ito, K Furuya, S Tsuda, K Konishi… - Hypertension …, 2004 - jstage.jst.go.jp
To clarify which parameter, diurnal pattern of blood pressure (BP) or level of BP variability,
has the stronger predictive value for fatal and nonfatal vascular events, vital status after a …
has the stronger predictive value for fatal and nonfatal vascular events, vital status after a …
A prognostic role of mean 24-h pulse pressure level for cardiovascular events in type 2 diabetic subjects under 60 years of age
S Nakano, K Konishi, K Furuya, K Uehara… - Diabetes …, 2005 - Am Diabetes Assoc
OBJECTIVE—To assess the prognostic role of ambulatory 24-h pulse pressure (PP) on
various vascular events in relatively young type 2 diabetic subjects under 60 years of age …
various vascular events in relatively young type 2 diabetic subjects under 60 years of age …
Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney …
M Kitada, Y Ogura, K Nitta, M Fujii… - Journal of Diabetes …, 2019 - Wiley Online Library
Abstract Aims/Introduction The objective of the present study was to elucidate the effect of
switching to teneligliptin from other dipeptidyl peptidase‐4 (DPP‐4) inhibitors on glucose …
switching to teneligliptin from other dipeptidyl peptidase‐4 (DPP‐4) inhibitors on glucose …
Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects
K Konishi, S Nakano, H Seto, S Tsuda… - diabetes research and …, 2009 - Elsevier
The aim of this study was to verify the possible association of visceral fat accumulation with
carotid atherosclerosis in order to identify the practical and feasible determinants for each …
carotid atherosclerosis in order to identify the practical and feasible determinants for each …
Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice
T Hirai, M Kitada, I Monno, E Oda… - Journal of Diabetes …, 2021 - Wiley Online Library
Abstract Aims/Introduction The aim of this study was to elucidate whether sodium–glucose
cotransporter 2 inhibitors (SGLT2is) treatment has any renoprotective effect for type 2 …
cotransporter 2 inhibitors (SGLT2is) treatment has any renoprotective effect for type 2 …
[HTML][HTML] Joint engineering team (JET) guidelines for internationalized domain names (IDN) registration and administration for Chinese, Japanese, and Korean
K Konishi, K Huang, H Qian, Y Ko - 2004 - rfc-editor.org
RFC 3743: Joint Engineering Team (JET) Guidelines for Internationalized Domain Names (IDN)
Registration and Administration for Chinese, Japanese, and Korean [RFC Home] [TEXT|PDF|HTML] …
Registration and Administration for Chinese, Japanese, and Korean [RFC Home] [TEXT|PDF|HTML] …
Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients
K Kanasaki, K Konishi, R Hayashi… - Journal of Diabetes …, 2013 - Wiley Online Library
Abstract Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that
increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic …
increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic …
Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering …
M Kitada, S Tsuda, K Konishi… - BMJ Open Diabetes …, 2017 - drc.bmj.com
Objective The objective of this study is to elucidate the effect of anagliptin on glucose/lipid
metabolism and renoprotection in patients with type 2 diabetic nephropathy. Methods …
metabolism and renoprotection in patients with type 2 diabetic nephropathy. Methods …
A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks
S Tsuda, S Nakano, K Konishi, D Koya - diabetes research and clinical …, 2008 - Elsevier
We assessed serum levels of total-and HMW-adiponectin as well as carotid intima–media
thickness (IMT) in relation to the levels of albuminuria in subjects with and without metabolic …
thickness (IMT) in relation to the levels of albuminuria in subjects with and without metabolic …